GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this offers value to shareholders.
German drugmaker Boehringer Ingelheim is considering the sale of its U.S. generics unit Roxane Labs for as much as 2 billion euros ($2.36 billion), Bloomberg said, citing people with knowledge of the matter.
Mindbody, a company that makes software to help run fitness and yoga studios, has selected banks for a potential initial public offering that could value it at more than $700 million, according to people familiar with the matter.
South Africa will spend 10 billion rand ($860 million) between 2015 and 2017 on life-prolonging HIV/AIDS treatment drugs, health authorities said on Wednesday, as studies show the prevalence of the virus is rising.
U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business daily Dagens Industri on Saturday.
Fitness tracking wristband maker Fitbit Inc is in talks with banks for its initial public offering in the United States, Bloomberg reported, citing people familiar with the matter.
Of every $10 spent on healthcare in the U.S., almost 90 cents is due to smoking, a new analysis says. Using recent health and medical spending surveys, researchers calculated that 8.7 percent of all healthcare spending, or $170 billion a year, is for illness caused by tobacco smoke, and public programs like Medicare and Medicaid paid for most of these costs.
Investors are pouring money into the operators of U.S. rehab centers as many more Americans get health care coverage for addiction treatment, driving up valuations and triggering a consolidation of businesses in the fragmented sector.
GlaxoSmithKline will this week inform U.S. staff of hundreds of job cuts in its biggest market as the drugmaker starts implementing a major cost-saving program, sources familiar with the matter said on Sunday.
Merck KGaA (MRCG.DE) aims to keep hold of its consumer healthcare unit, it said on Friday, pledging to develop a business that is expected to generate 2014 sales of $1 billion for the German drugs and chemicals company.
Australia said on Sunday it would list state-owned health insurer Medibank Private Ltd (MPL.AX) with a market capitalization of A$5.679 billion ($4.9 billion), exceeding the top end of a range indicated in its IPO filing a month earlier.
Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
About 160 Chinese health workers arrived on Saturday in Liberia, where they are due to staff a new $41 million Ebola clinic that, unlike most other foreign interventions, is being built and fully run by Chinese personnel.
President Barack Obama's plan to extend private health coverage to the uninsured entered a new uncertain phase on Saturday as U.S. government-backed online insurance marketplaces opened their 2015 plans to millions of potential enrollees.
Indian generic drugmaker Aurobindo Pharma Ltd (ARBN.NS) said on Wednesday its U.S. unit won a bankruptcy auction to buy nutritional supplements maker Natrol Inc for $132.5 million.
Subscribe to VCpost newsletter
- Avoid These Mistakes When Pitching to Venture Capitalists
- Arctic Bearz - A Unique NFT Linked With the Preservation of Polar Bears
- Non-fungible tokens: Multi Billion-dollar Industry beyond JPEGs
- Samurai Cats is the latest NFT project associated with art by Hiro Ando.
- Discover the VaaS Technology That Could Help to Keep Your Business Safe
- What are the Benefits of Running a Virtual/Hybrid Investor Event?
- 5 Tips On Managing Your Addiction Withdrawal Symptoms
- Top International Economic Events of the 21st Century